Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
Human serum paraoxonase 1 (PON1) is an enzyme with esterase activity, and is physically bound to high-density lipoproteins (HDL). It plays a key role in the action of HDL toward protection of lipoprotein and biological membrane against oxidative damage. It may have a protective role against atherosc...
Main Authors: | Sunil K Kota, Lalit K Meher, Siva K Kota, Sruti Jammula, S. V. S. Krishna, Kirtikumar D Modi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=3;spage=402;epage=412;aulast=Kota |
Similar Items
-
Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents
by: Moushira Erfan Zaki, et al.
Published: (2014-01-01) -
Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients
by: Mehrdad Solati, et al.
Published: (2012-10-01) -
Neuropsychiatric screening in type 2 diabetes mellitus
by: Sunil K Kota, et al.
Published: (2012-01-01) -
Serum Paraoxonase Levels in Type 2 Diabetes Mellitus Patients: A Case-Control Study
by: D Namitha, et al.
Published: (2015-06-01) -
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus
by: Y. Atamer, et al.
Published: (2013-01-01)